Category: Prescription Drugs

Health Policy News – January 2020

Introduction Happy 2020 Health Policy News readers! We hope you all had an enjoyable and relaxing holiday season. As we continue to await the proposed Marketplace guidance for 2021, we wanted to take this opportunity to share recent health policy developments from the federal and state levels. In breaking news, our first article includes our ...

California’s Innovative Approach to Address Rising Pharmaceutical Costs

Addressing rising prescription drug costs has been a top priority for California Governor Gavin Newsom’s administration. Health Policy News reported early in his term about the Governor’s Executive Order that authorized the state’s Department of Health Care Services to negotiate prescription drug prices for the state’s Medicaid program. Governor Newsom’s efforts continued into 2020 with ...

Health Policy News – December 2019

Health Policy News is once again dedicating our December edition to reflecting on the past year’s high-profile healthcare topics—providing context, summarizing recent developments, and predicting what activity is in store for these issues in the coming year. HPN editors Lisa Kaplan Howe and Margot Thistle have dedicated this edition to reflect on 2019 and forecast ...

2020 Prediction: Continued Focus on Ensuring Access to Healthcare, Prescription Drugs, and Healthy Food to Combat Diet-Related Illness

Over the past year, Health Policy News readers were drawn to topics that were top of mind for many policymakers, as well as articles that detailed innovative solutions to complex problems like controlling health costs and expanding access to healthcare. As 2019 comes to a close, this piece revisits these popular topics, providing updates on ...

Highlights from The Workers Compensation Research Institute 2019 Annual Issues and Research Conference

February 28-March 1, 2019, marked the 35th annual Workers Compensation Research Institute (WCRI) Issues and Research Conference. The theme of this year’s event, “Breaking Down Barriers to Improve Injured Workers’ Outcomes,” signified two core ideas that were evident in each session. The first was that workers compensation can no longer operate in a silo. As ...

2019 Brings Progress on Prescription Drug Cost Control Efforts at State and Federal Level

As states and the federal government grapple with how best to address the issue of rising prescription drug costs, various models have emerged at the federal level that are similar to efforts underway at the State level. The Administration has called upon states to create innovative approaches to state Medicaid programs, particularly by examining value-based ...

1115 Waiver Decisions issued by CMS

As we addressed in our report this past Spring, the use of Section 1115 Medicaid Waivers to address rising drug costs was a notable feature of the Federal administration’s recent drug proposal, and is an emerging policy trend.[1] The Federal administration’s 2019 budget proposes providing five states with Medicaid demonstration authority to test “drug coverage ...

Health Policy News October Edition

 Introduction This month’s edition of Health Policy News focuses on recent developments relative to drug policy, which has been an ever-growing focus at the State and Federal level. We continue our coverage of efforts relative to drug cost control with short summaries of recent decisions on Section 1115 Waivers submitted by Massachusetts and Oklahoma, and ...